Market Overview:
The global IVD testing market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of diseases, growing demand for personalized medicine, and technological advancements in the field of diagnostics. The global IVD testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into instruments, reagents & kits, data management software & services. The instruments segment accounted for a major share in 2017 and is projected to grow at a CAGR of 6% during the forecast period. This can be attributed to technological advancements in this field that have led to introduction of novel products with enhanced features such as integrated systems and point-of-care testing devices. On the basis of application, hospitals accounted for majority share in 2017 and are projected to grow at a CAGR 5%.
 Testing Industry Outlook.svg)
Product Definition:
In vitro diagnostics (IVD) is a term used in the medical and laboratory fields for diagnostic tests that are performed on tissue or fluid samples that have been removed from a living organism, as opposed to those performed on whole organisms. IVD testing is important because it can provide information about a person's health that would not be available otherwise. For example, many types of cancer can be detected through the use of specific IVD tests.
Instruments:
Instruments are used in IVD (In Vitro Diagnostic) testing for the purpose of providing accurate results. The factors that propel market growth include growing prevalence of chronic diseases, increasing demand for early diagnostic methods and technological advancements such as high throughput systems and automated robotic devices.
Reagents:
Reagents are substances that help in the detection of disease, infection or other medical conditions. Reagents can be categorized into two types: those used for diagnosis and those used for research. Diagnostic reagents are further segmented into four sub-categories namely, kits & assays, stains & fixatives and probes & primers whereas research reagent is classified as antibodies & substrates among others.
Application Insights:
The others application segment held the largest share of over 30.0% in 2017. The other applications include research institutes, clinical laboratories and diagnostic centers that perform a variety of tests on samples taken from patients for diagnosis or evaluation purposes. These organizations require automated systems to store and retrieve data related to the test results as well as comply with regulatory requirements for safety & quality.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and rising healthcare expenditure in this region. Moreover, increasing cases of chronic diseases are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over a CAGR exceeding 7% during the forecast period owing to factors such as improving healthcare infrastructure & facilities along with growing target population base especially in countries like India & China thereby boosting product demand throughout this study period 8th Edition).
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and heart diseases is expected to drive the demand for IVD tests.
- Rising awareness about early diagnosis and treatment of various diseases is also anticipated to fuel the growth of IVD testing market.
- Technological advancements in diagnostic equipment are likely to boost the adoption of IVD tests, thereby propelling the market growth.
- Growing demand for personalized medicine will create opportunities for IVD testing market players over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
IVD (In Vitro Diagnostic) Testing Market Research Report
By Type
Instruments, Reagents, Data Management Software, Services
By Application
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others
By Companies
Siemens Healthineers, F. Hoffmann-La Roche, Danaher (Beckman Coulter Inc), Abbott Laboratories, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global IVD (In Vitro Diagnostic) Testing Market Report Segments:
The global IVD (In Vitro Diagnostic) Testing market is segmented on the basis of:
Types
Instruments, Reagents, Data Management Software, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthineers
- F. Hoffmann-La Roche
- Danaher (Beckman Coulter Inc)
- Abbott Laboratories
- Thermo Fisher Scientific
 Testing Market Overview.svg)
Highlights of The IVD (In Vitro Diagnostic) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Reagents
- Data Management Software
- Services
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVD (In Vitro Diagnostic) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD testing is a process of diagnosing diseases or conditions in vitro, which means outside the body. This type of testing can be used to diagnose a wide variety of medical conditions, including cancer and heart disease. IVD tests are often used to check for abnormalities in blood cells or tissues.
Some of the key players operating in the ivd (in vitro diagnostic) testing market are Siemens Healthineers, F. Hoffmann-La Roche, Danaher (Beckman Coulter Inc), Abbott Laboratories, Thermo Fisher Scientific.
The ivd (in vitro diagnostic) testing market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVD (In Vitro Diagnostic) Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 IVD (In Vitro Diagnostic) Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 IVD (In Vitro Diagnostic) Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the IVD (In Vitro Diagnostic) Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global IVD (In Vitro Diagnostic) Testing Market Size & Forecast, 2020-2028
4.5.1 IVD (In Vitro Diagnostic) Testing Market Size and Y-o-Y Growth
4.5.2 IVD (In Vitro Diagnostic) Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Reagents
5.2.3 Data Management Software
5.2.4 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IVD (In Vitro Diagnostic) Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IVD (In Vitro Diagnostic) Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Reagents
9.6.3 Data Management Software
9.6.4 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Diagnostic Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Reagents
10.6.3 Data Management Software
10.6.4 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Diagnostic Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Reagents
11.6.3 Data Management Software
11.6.4 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Diagnostic Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Reagents
12.6.3 Data Management Software
12.6.4 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Diagnostic Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Reagents
13.6.3 Data Management Software
13.6.4 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Diagnostic Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IVD (In Vitro Diagnostic) Testing Market: Competitive Dashboard
14.2 Global IVD (In Vitro Diagnostic) Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthineers
14.3.2 F. Hoffmann-La Roche
14.3.3 Danaher (Beckman Coulter Inc)
14.3.4 Abbott Laboratories
14.3.5 Thermo Fisher Scientific
